Mitochondrial oxidative phosphorylation system and mitochondrial phospholipid membranes (OXPHOS/MPM)

The mitochondrial oxidative phosphorylation (OXPHOS) system and the associated mitochondrial phospholipid membranes, particularly the inner membrane rich in cardiolipin, constitute the primary energy-generating machinery of the eukaryotic cell. This system comprises five multi-subunit enzyme complexes (Complex I-V) that facilitate electron transport and proton pumping to drive ATP synthesis (StatPearls, 2023). The structural integrity and efficiency of these complexes are heavily dependent on the unique phospholipid environment, where cardiolipin acts as a critical scaffold for the formation of respiratory supercomplexes and the maintenance of cristae morphology (PubMed, 2021). Dysregulation of this system is central to the pathogenesis of primary mitochondrial diseases, such as Barth syndrome and MELAS, and plays a significant role in secondary conditions like heart failure and neurodegeneration (NIH, 2022). Therapeutic strategies include the use of small molecules like elamipretide, which binds to cardiolipin to stabilize the membrane and enhance OXPHOS efficiency, or inhibitors like metformin that modulate Complex I to affect systemic metabolism (PubChem, 2024). Because this system is fundamental to aerobic life, pharmacological targeting requires precise calibration to avoid systemic toxicity or catastrophic energy failure.

Other names

Electron transport chainMitochondrial respiratory chainMitochondrial inner membraneCardiolipin-rich membranesMitochondrial energy systemRespiratory supercomplexes

Stabilization of cardiolipin to maintain mitochondrial cristae structure and respiratory supercomplex integrity, inhibition of specific respiratory chain complexes (I-V) to modulate metabolic flux, or uncoupling of the proton gradient to dissipate the electrochemical potential as heat.